{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:33:34Z","timestamp":1792089214774,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.drudis.2024.104012","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:47:44Z","timestamp":1714751264000},"page":"104012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Vaginal drug delivery system: A promising route of drug administration for local and systemic diseases"],"prefix":"10.1016","volume":"29","author":[{"given":"M. Tamil Mani","family":"Subi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandhakumar","family":"Selvasudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Vasanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104012_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.drudis.2024.104012_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3746\/pnf.2019.24.3.225","article-title":"Techniques for formulation of nanoemulsion drug delivery system: a review","volume":"24","author":"Kumar","year":"2019","journal-title":"Prev Nutr Food Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0015","series-title":"Nanotechnology-based approaches for targeting and delivery of drugs and genes","first-page":"322","article-title":"Chapter 10 \u2013 Bioadhesive polymers for targeted drug delivery","author":"Kumar","year":"2017"},{"key":"10.1016\/j.drudis.2024.104012_b0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0025","first-page":"142","article-title":"A review on vaginal drug delivery system","volume":"4","author":"Khan","year":"2015","journal-title":"Rajiv Gandhi Univ Heal Sci J Pharm Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0030","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.3390\/ma13225270","article-title":"Cellulose-based hydrogels as sustained drug-delivery systems","volume":"13","author":"Ciolacu","year":"2020","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.drudis.2024.104012_b0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2024.104012_b0040","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/17425247.2014.924499","article-title":"Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development","volume":"11","author":"Wong","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.drudis.2024.104012_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fmed.2018.00181","article-title":"The vaginal microenvironment: the physiologic role of Lactobacilli","volume":"5","author":"Amabebe","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.drudis.2024.104012_b0050","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.3390\/ijms21218266","article-title":"The cervicovaginal mucus barrier","volume":"21","author":"Lacroix","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0055","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.resmic.2017.04.001","article-title":"The role of lactic acid production by probiotic Lactobacillus species in vaginal health","volume":"168","author":"Tachedjian","year":"2017","journal-title":"Res Microbiol"},{"key":"10.1016\/j.drudis.2024.104012_b0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/10717544.2014.928760","article-title":"Advanced topical drug delivery system for the management of vaginal candidiasis","volume":"23","author":"Johal","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.drudis.2024.104012_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.03.012","article-title":"Gels as vaginal drug delivery systems","volume":"318","author":"das Neves","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2024.104012_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114543","article-title":"In vitro and ex vivo models for evaluating vaginal drug delivery systems","volume":"191","author":"Shapiro","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2024.104012_b0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10544-019-0385-x","article-title":"Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract","volume":"21","author":"Pisano","year":"2019","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.drudis.2024.104012_b0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.carbpol.2018.03.054","article-title":"Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration","volume":"192","author":"Maestrelli","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.drudis.2024.104012_b0085","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.2147\/IJN.S272736","article-title":"Antibacterial activity of chitosan nanoparticles against pathogenic N. gonorrhoea","volume":"15","author":"Alqahtani","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.drudis.2024.104012_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105801","article-title":"Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine","volume":"161","author":"Tu\u011fcu-Demir\u00f6z","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2018.11.022","article-title":"Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W\/S emulsions containing ciprofloxacin","volume":"554","author":"Campa\u00f1a-Seoane","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2024.104012_b0100","first-page":"130","article-title":"Poly(lactic acid) nano-fibers as drug-delivery systems: opportunities and challenges","volume":"4","author":"Fattahi","year":"2019","journal-title":"Nanomed Res J"},{"key":"10.1016\/j.drudis.2024.104012_b0105","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3390\/pharmaceutics15051529","article-title":"Development of thermoresponsive hydrogels with mucoadhesion properties loaded with metronidazole gel-flakes for improved bacterial vaginosis treatment","volume":"15","author":"Permana","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2024.104012_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106494","article-title":"Design and evaluation of antibacterials crosslinked chitosan nanoparticle as a novel carrier for the delivery of metronidazole to treat bacterial vaginosis","volume":"186","author":"Nayak","year":"2024","journal-title":"Microb Pathog"},{"key":"10.1016\/j.drudis.2024.104012_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128212","article-title":"Metronidazole loaded chitosan-phytic acid polyelectrolyte complex nanoparticles as mucoadhesive vaginal delivery system for bacterial vaginosis","volume":"255","author":"Nayak","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2024.104012_b0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2018.12.011","article-title":"Chitosan-hydroxypropyl methylcellulose tioconazole films: a promising alternative dosage form for the treatment of vaginal candidiasis","volume":"556","author":"Calvo","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2024.104012_b0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejps.2017.12.023","article-title":"Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: Formulation development and in vivo therapeutic efficacy in rats","volume":"114","author":"Salah","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0130","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3390\/pharmaceutics14122802","article-title":"Preparation and evaluation of modified chitosan nanoparticles using anionic sodium alginate polymer for treatment of ocular disease","volume":"14","author":"Bhosale","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2024.104012_b0135","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/acs.molpharmaceut.8b00609","article-title":"Design, characterization, and biopharmaceutical behavior of nanoparticles loaded with an HIV-1 fusion inhibitor peptide","volume":"15","author":"Ariza-S\u00e1enz","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2024.104012_b0140","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/mp4007024","article-title":"Increased dapivirine tissue accumulation through vaginal film codelivery of dapivirine and tenofovir","volume":"11","author":"Akil","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2024.104012_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12010001","article-title":"Rational design of a multipurpose bioadhesive vaginal film for co-delivery of dapivirine and levonorgestrel","volume":"12","author":"Li","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2024.104012_b0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.actbio.2018.10.003","article-title":"Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines","volume":"82","author":"Kim","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.drudis.2024.104012_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2024.104012_b0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.06.028","article-title":"Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA","volume":"236","author":"Furst","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2024.104012_b0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10717544.2019.1568622","article-title":"A thermosensitive gel based on w1\/o\/w2 multiple microemulsions for the vaginal delivery of small nucleic acid","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.drudis.2024.104012_b0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"das Neves","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2024.104012_b0175","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/adhm.201300519","article-title":"Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth","volume":"3","author":"Yang","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.drudis.2024.104012_b0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/ma12030407","article-title":"Corrosion of metallic biomaterials: a review","volume":"12","author":"Eliaz","year":"2019","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.drudis.2024.104012_b0185","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.4049\/jimmunol.165.9.5077","article-title":"Vaginal mucosa serves as an inductive site for tolerance","volume":"165","author":"Black","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2024.104012_b0190","first-page":"406","article-title":"Trichomonas vaginalis: clinical relevance, pathogenicity and diagnosis","volume":"42","author":"Edwards","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.drudis.2024.104012_b0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijpddr.2012.04.002","article-title":"Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia","volume":"2","author":"Leitsch","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.drudis.2024.104012_b0200","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10837450.2018.1481430","article-title":"Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis","volume":"24","author":"Fernando","year":"2019","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.drudis.2024.104012_b0205","doi-asserted-by":"crossref","first-page":"10554","DOI":"10.3390\/ijms221910554","article-title":"Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (Review of Literature)","volume":"22","author":"Smolarz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106501","article-title":"Mucoadhesive 3D printed vaginal ovules to treat endometriosis and fibrotic uterine diseases","volume":"188","author":"Teworte","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.drudis.2024.104012_b0215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13287-017-0706-z","article-title":"miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo","volume":"8","author":"Liang","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.drudis.2024.104012_b0220","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41434-018-0042-7","article-title":"Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model","volume":"25","author":"Egorova","year":"2018","journal-title":"Gene Ther"},{"key":"10.1016\/j.drudis.2024.104012_b0225","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.3390\/nano11123257","article-title":"Homing peptide-based targeting of tenascin-C and fibronectin in endometriosis","volume":"11","author":"Sim\u00f3n-Gracia","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.drudis.2024.104012_b0230","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10717544.2019.1622609","article-title":"Development of an intravaginal ring delivering simultaneously anastrozole and levonorgestrel: a pharmacokinetic perspective","volume":"26","author":"Nave","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.drudis.2024.104012_b0235","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/jcm10061270","article-title":"Emergency cervical cerclage","volume":"10","author":"Wierzchowska-Opoka","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.drudis.2024.104012_b0240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/ten.tea.2019.0210","article-title":"Injectable silk-based hydrogel as an alternative to cervical cerclage: a rabbit study","volume":"26","author":"Zhang","year":"2019","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.drudis.2024.104012_b0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc6245","article-title":"Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth","volume":"13","author":"Zierden","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2024.104012_b0250","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1039\/D2NA00834C","article-title":"Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions","volume":"5","author":"Taylor","year":"2023","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.drudis.2024.104012_b0255","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/jcm8101625","article-title":"Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring","volume":"8","author":"Fox","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.drudis.2024.104012_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2017.07.360","article-title":"Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery","volume":"58","author":"Yu","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.drudis.2024.104012_b0265","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/acsbiomaterials.0c00826","article-title":"Nanoparticle-mediated simultaneous downregulation of placental Nrf2 and sFlt1 improves maternal and fetal outcomes in a preeclampsia mouse model","volume":"6","author":"Li","year":"2020","journal-title":"ACS Biomater Sci Eng"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T02:32:35Z","timestamp":1716604355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1359644624001375"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104012","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal drug delivery system: A promising route of drug administration for local and systemic diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104012"}}